DexCom (DXCM) Q4 2023 Earnings Call Transcript : vimarsana.c

DXCM earnings call for the period ending December 31, 2023.

Related Keywords

Australia , Malaysia , Ireland , United States , Japan , Germany , New Zealand , Matt Miksic , America Merrill Lynch , Mathew Blackman , Sean Christensen , Margaret Andrew , Kevin Sayer , Larry Biegelsen , Steve Lichtman Oppenheimer , Joanne Wuensch Citi , Mike Kratky Leerink , Matthew Obrien Piper Sandler , Matt Obrien , Jereme Sylvain , Joanne Wuensch , Robbie Marcus , Matt Taylor , Plovanic Canaccord Genuity , Marie Thibault , Canaccord Genuity , Matthew Obrien , William Blair , Matt Miksic Barclays , Michael Polark , Josh Jennings , Piper Sandler , Jayson Bedford Raymond James , Danielle Antalffy , Jeff Johnson , Margaret Andrew William Blair , Steve Lichtman , Jayson Bedford , Robbie Marcus Jpmorgan , Raymond James , Chris Pasquale , Mike Kratky , Wolfe Research , Wells Fargo , Barclays , Travis Steed Bank , Mathew Blackman Stifel Financial Corp , Company Analyst , Matt Taylor Stifel Financial Corp , Citigroup , Exchange Commission , Chris Pasquale Nephron Research Analyst , Michael Polark Wolfe Research Analyst , Linkedin , Dexcom Investor Relations , Motley Fool Stock Advisor , Stock Advisor , Chief Executive , Investor Day , Fargo Securities , Does International , Travis Steed , Matthewo Brien , Will Plovanic , Matto Brien , Does Dexcom , Wells Fargo Securities , Stifel Financial , Nephron Research , Dexcom , Nexcom , Chief Executive Officer , Operating Profit Margin , Fourth Quarter ,